Vor Biopharma
VOR
VOR
49 hedge funds and large institutions have $151M invested in Vor Biopharma in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
-9
Holders Change %
-15.52%
% of All Funds
0.83%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
10
Increased
11
Reduced
16
Closed
18
Calls
$12K
Puts
–
Net Calls
+$12K
Net Calls Change
-$1K
Top Buyers
| 1 |
BBA
Baker Bros. Advisors
New York
|
$5.66M |
| 2 |
PBA
Paradigm Biocapital Advisors
New York
|
$6.48M |
| 3 |
Millennium Management
New York
|
$1.44M |
| 4 |
E
Ergoteles
New York
|
$430K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
$345K |
Top Sellers
| 1 |
BlackRock
New York
|
$2.19M |
| 2 |
State Street
Boston,
Massachusetts
|
$205K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
$533K |
| 4 |
Northern Trust
Chicago,
Illinois
|
$94K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
$0 |
